Infanrix - Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed 25 ug / .5mL; 8 ug / .5mL; 25 ug / .5mL; 10 [iU] / .5mL; 25 [iU] / .5mL Suspension 0.5 mL
Reference details for licensed healthcare facility review and verification.
| NDC 11 | 58160-0810-52 |
|---|---|
| Product NDC | 58160-0810 |
| Generic Drug Name | Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed |
| Brand Name | Infanrix |
| Manufacturer | GlaxoSmithKline Biologicals SA |
| Strength | 25 ug / .5mL; 8 ug / .5mL; 25 ug / .5mL; 10 [iU] / .5mL; 25 [iU] / .5mL |
| Dosage Form | Suspension |
| Drug Type | Intramuscular |
| Package Quantity | 10 Syringe |
| Package Description | 10 SYRINGE in 1 CARTON (58160-810-52) / .5 mL in 1 SYRINGE (58160-810-43) |
| Active Ingredients | Bordetella Pertussis Filamentous Hemagglutinin Antigen (Formaldehyde Inactivated); Bordetella Pertussis Pertactin Antigen (Formaldehyde Inactivated); Bordetella Pertussis Toxoid Antigen (Formaldehyde, Glutaraldehyde Inactivated); Clostridium Tetani Toxoid Antigen (Formaldehyde Inactivated); Corynebacterium Diphtheriae Toxoid Antigen (Formaldehyde Inactivated) |
| Marketing Category | BLA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed 25 ug / .5mL; 8 ug / .5mL; 25 ug / .5mL; 10 [iU] / .5mL; 25 [iU] / .5mL Suspension is tracked under NDC 58160-0810-52 and rolls up into product family 58160-0810. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.
- Package configuration: 10 Syringe.
- Manufacturer: GlaxoSmithKline Biologicals SA.
- Dosage form: Suspension.
- Family size: 1 indexed presentation.
Click a tag to refine the catalog view around this product reference.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Drug Shortage Information
Public sources include an NDC-level label source plus FDA and CDC public vaccine-supply references relevant to Infanrix/DTaP shortage history.
Infanrix - Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed 25 ug / .5mL; 8 ug / .5mL; 25 ug / .5mL; 10 [iU] / .5mL; 25 [iU] / .5mL Suspension 0.5 mL, NDC 58160-0810-52, is a GlaxoSmithKline Biologicals SA 25 ug / .5mL; 8 ug / .5mL; 25 ug / .5mL; 10 [iU] / .5mL; 25 [iU] / .5mL suspension presentation packaged as 10 Syringe. Historical public shortage information is available for this product reference.
NDC search formats
- Canonical NDC 11: 58160-0810-52
- Digits-only NDC 11: 58160081052
- Possible 10-digit display format: 58160-810-52 (5816081052)
Helpful product links
- Search by brand name: Infanrix
- NDC 11: 58160-0810-52
- Product family NDC: 58160-0810
- VA classification code: IM109
- VA classification code description: VACCINES/TOXOIDS, OTHER
- CMOP ID: I0350
- VUID: 4016289
- UNSPSC code: 51201631
- Misc. Order Numbers: 723968